Table 2.
Characteristics of patients, surgery and treatments according type of immediate breast reconstruction.
| 1 patient excluded: lipofilling only | IBR with implant |
IBR with LDF |
Chi2 |
|||
|---|---|---|---|---|---|---|
| Nb | % | Nb | % | p | ||
| Age | ≤ median 49 | 303 | 55.0 | 79 | 40.3 | <0.0001 |
| >49 years | 248 | 45.0 | 117 | 59.7 | ||
| Indication | Primary | 395 | 71.7 | 153 | 78.1 | <0.0001 |
| Local recurrence | 44 | 8.0 | 42 | 21.4 | ||
| Prophylactic | 112 | 20.3 | 1 | 0.5 | ||
| Bilateral | No | 417 | 75.7 | 196 | 100 | <0.0001 |
| Yes | 134 | 24.3 | 0 | |||
| Years | 2016 | 119 | 21.6 | 40 | 20.4 | <0.0001 |
| 2017 | 112 | 20.3 | 59 | 30.1 | ||
| 2018 | 151 | 27.4 | 71 | 36.2 | ||
| 2019 | 169 | 30.7 | 26 | 13.3 | ||
| Radiotherapy | No | 427 | 77.5 | 73 | 37.2 | <0.0001 |
| PMRT | 78 | 14.2 | 29 | 14.8 | ||
| Previous RTH | 46 | 8.3 | 42 | 21.4 | ||
| NAC + N-RTH | 0 | 0 | 52 | 26.5 | ||
| Neo-adjuvant | No | 515 | 93.5 | 128 | 65.3 | <0.0001 |
| chemotherapy | Yes | 36 | 6.5 | 68 | 34.7 | |
| Tobacco | No | 153 p | 80.6 | 148 | 75.5 | 0.082 |
| Yes | 107 | 19.4 | 48 | 24.5 | ||
| Diabetes | No | 549 | 99.6 | 190 | 96.9 | 0.005 |
| Yes | 2 | 0.4 | 6 | 3.1 | ||
| ASA status | 1 | 268 | 48.7 | 69 | 35.2 | 0.005 |
| 2 | 273 | 49.6 | 123 | 62.8 | ||
| 3 | 9 | 1.6 | 4 | 2.0 | ||
| Breast cup size | A-B | 324 | 58.8 | 88 | 44.9 | 0.003 |
| C | 150 | 27.2 | 67 | 34.2 | ||
| > C | 77 | 14.0 | 41 | 20.9 | ||
| Histology | DCIS | 121 | 22.0 | 32 | 16.3 | <0.0001 |
| Ductal | 252 | 45.7 | 122 | 62.2 | ||
| Lobular | 66 | 12.0 | 35 | 17.9 | ||
| Others | 1 | 0.2 | 4 | 2.0 | ||
| No cancer | 111 | 20.1 | 3 | 1.5 | ||
| Axillary surgery | No | 229 | 41.6 | 89 | 45.4 | <0.0001 |
| SLNB | 292 | 53.0 | 54 | 27.6 | ||
| ALND | 30 | 5.4 | 53 | 27.0 | ||
| Robotic NSM | No | 497 | 90.2 | 139 | 70.9 | <0.0001 |
| or endoscopic | Yes | 54 | 9.8 | 57 | 29.1 | |
Legend: PMRT: post mastectomy radiotherapy, RTH: radiotherapy, NAC: neo-adjuvant chemotherapy, N-RTH: neo-adjuvant radiotherapy, DCIS: ductal carcinoma in-situ, SLNB: sentinel lymph node biopsy, ALND: axillary lymph node dissection, LDF: latissimus dorsi-flap, NSM: nipple sparing mastectomy.